Stromectol

This medicine is developed to target parasitic infestations like strongyloidiasis and is intended to alleviate symptoms by eradicating the underlying parasite.

Strengths: 3 · 6 · 12mg

Medicine details

Therapeutic class

Anthelmintic

Pharmacological class

Avermectin

Contraindications

hypersensitivity to ivermectin

Precautions and warnings

avoid until treatment is complete; monitor for allergic reactions

Minor side effects

nausea; abdominal ache

Moderate side effects

dizziness; rash

Dosage forms

Tablet

Administration route

Oral use

Prescription status

POM

Manufacturer

MSD

Onset Time

1–2 days

Duration

single dose

Storage instructions

Store at room temperature below 30°C.

Drug interactions

warfarin

Age restrictions

Weight-based dosing requried.

Pregnancy and breastfeeding

Pregnancy: Generally avoided. Breastfeeding: Excreted in breast milk; avoid use.

Serious side effects

anaphylaxis — requires immediate medical attention; toxic epidermal necrolysis — requires immediate medical attention

Patient summary

This medicine is developed to target parasitic infestations like strongyloidiasis and is intended to alleviate symptoms by eradicating the underlying parasite.

Mechanism of action

Ivermectin binds selectively to glutamate-gated chloride ion channels in invertebrate nerve and muscle cells. This increases the permeability of the cell membrane to chloride ions, resulting in hyperpolarisation of the nerve or muscle cell, resulting in paralysis and death of the parasite.

Stromectol

This medicine is developed to target parasitic infestations like strongyloidiasis and is intended to alleviate symptoms by eradicating the underlying parasite.

Editorial Notes

  • Active ingredient(s): Ivermectin
  • Listed indication(s): Strongyloidiasis, Scabies

Usually available as

  • 60 tablets - 3 mg644-3-mg-12447
  • 30 tablets - 6 mg644-6-mg-11267
  • 30 tablets - 12 mg644-12-mg-12415